Abbot Laboratories (ABT) - Get Report shares were downgraded to "market perform" from "outperform" by analysts at BMO Tuesday. 

The firm made the downgrade on valuation, noting that the stock has risen nearly 20% year to date and the company's recent acquisitions of St. Jude Medical and Alere (ALR) are already represented in the company's stock price.